Literature DB >> 17956274

Lifespan regulation of conventional protein kinase C isotypes.

D Carmena1, A Sardini.   

Abstract

Plasma membrane translocation, following allosteric binding of second messengers, initiates the signal transduction process mediated by cPKC [conventional PKC (protein kinase C)] isotypes. Mechanisms regulating the lifespan of the active enzyme such as its phosphorylation, internalization, dephosphorylation and degradation are key elements of the signalling network. The understanding of such mechanisms is essential for the design of therapeutic strategies targeting PKC isoenzymes.

Mesh:

Substances:

Year:  2007        PMID: 17956274     DOI: 10.1042/BST0351043

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  5 in total

Review 1.  The life and death of protein kinase C.

Authors:  Christine M Gould; Alexandra C Newton
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

2.  Heat shock proteins regulate activation-induced proteasomal degradation of the mature phosphorylated form of protein kinase C.

Authors:  Michelle A Lum; Gregor M Balaburski; Maureen E Murphy; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

3.  Agonist-induced down-regulation of endogenous protein kinase c α through an endolysosomal mechanism.

Authors:  Michelle A Lum; Krista E Pundt; Benjamin E Paluch; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

Review 4.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

5.  Massive endocytosis triggered by surface membrane palmitoylation under mitochondrial control in BHK fibroblasts.

Authors:  Donald W Hilgemann; Michael Fine; Maurine E Linder; Benjamin C Jennings; Mei-Jung Lin
Journal:  Elife       Date:  2013-11-26       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.